THIRD QUARTER 2022 (JUL – SEP)
Net sales amounted to
For comparable units, sales increased by 39 percent.
Operating profit amounted to
Net profit amounted to
Cash flow from operating activities amounted to an inflow of
FIRST NINE MONTHS OF 2022 (JAN–SEP)
Net sales amounted to
For comparable units, sales increased by 39 percent.
Operating profit amounted to
Net profit amounted to
Cash flow from operating activities amounted to an inflow of
This report, in its entirety, is available through the attachment or via:
https://surgicalscience.com/aktien/pressmeddelanden/
https://surgicalscience.com/aktien/finansiella-rapporter/
This is a translation of the Swedish version of the interim report. When in doubt, the Swedish wording prevails.
© Modular Finance, source